60 Degrees Pharmaceuticals, Inc. SEC filings SXTPW
60 Degrees Pharmaceuticals, Inc. has 222 filings in SEC EDGAR's recent list, going back to Oct 18, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | Mar 13, 2026 | — |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| 424B5 | Prospectus supplement | Mar 2, 2026 | — |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| 424B4 | Prospectus | Jul 16, 2025 | — |
| S-1 | Registration statement | Jul 7, 2025 | — |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| S-1 | Registration statement | Feb 14, 2025 | — |
| 424B5 | Prospectus supplement | Feb 6, 2025 | — |
| 424B5 | Prospectus supplement | Jan 30, 2025 | — |
| S-3 | Shelf registration | Sep 19, 2024 | — |
| 424B5 | Prospectus supplement | Aug 2, 2024 | — |
| 424B5 | Prospectus supplement | Jul 26, 2024 | — |
| 424B5 | Prospectus supplement | Jul 24, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| S-3 | Shelf registration | Jul 12, 2024 | — |
| 424B4 | Prospectus | Jan 31, 2024 | — |
| S-1 | Registration statement | Jan 22, 2024 | — |
| 424B4 | Prospectus | Jul 13, 2023 | — |
| S-1/A | Amended registration statement | Jun 8, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| S-1/A | Amended registration statement | May 19, 2023 | — |
| S-1/A | Amended registration statement | Apr 28, 2023 | — |
| S-1/A | Amended registration statement | Apr 3, 2023 | — |
| S-1 | Registration statement | Jan 31, 2023 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTP (Nasdaq), SXTPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1946563
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.